In ErbB2-induced mammary tumorigenesis, Ink4a/Arf+/− mice showed decreased p16INK4a, increased Ki-67 expression, increased cyclin D1 protein but decreased mammary tumor apoptosis [111]. This evidence concerns the gene ERBB2 and breast cancer.